1. Larizadeh MH, Damghani MA, Shabani M. Epidemiological characteristics of head and neck cancers in southeast of Iran. Iran J Cancer Prev. 2014; 7(2):80-6.
2. Ajayi OF, Adeyemo WL, Ladeinde AL,
Ogunlewe M.O,
Effiom O.A,
Omitola O.G, et al. Primary malignant neoplasms of orofacial origin: a retrospective review of 256 cases in a Nigerian tertiary hospital. Int J Oral Maxillofac Surg. 2007; 36(5):403-8.
3. Etemad-Moghadam S, Tirgary F, Keshavarz S, Alaeddini M. Head and neck non-Hodgkin's lymphoma: a 20-year demographic study of 381 cases. Int J Oral Maxillofac Surg. 2010; 39(9): 869-72.
4. Akbari ME, Bastani Z, Mokhtari S, Atarbashi Moghadam S. Oral Lymphoma Prevalence in Iranian Population: A Multicenter Retrospective Study. Iran J Cancer Prev. 2015;8(6):e4124.
5. Mohtasham N, Babakoohi S, Sarraf-Yazdy M, Sadr B, Ghaffarzadegan K, Shiva A, et al. Oral and jaw lymphoma in an Iranian population. J Craniofac Surg. 2011;22(3):868-70.
6. Andisheh Tadbir A1, Mehrabani D, Heydari ST. Primary malignant tumors of orofacial origin in Iran. J Craniofac Surg. 2008;19(6):1538-41.
7. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2009; 20(3):556-63.
8. Razavi SM, Siadat S, Rahbar P, Hosseini SM, Shirani AM. Trends in oral cancer rates in Isfahan, Iran during 1991-2010. Dent Res J (Isfahan). 2012; 9(Suppl 1):S88-S93.
9. Baharvand M, Mortazavi H. Characteristics of Hodgkin lymphoma in a defined group of Iranian pediatric patients. Asian Pac J Cancer Prev. 2014; 15(13):5167-9.
10. Basirat M, Rabiei M, Bashardoust N. Incidence of Head and Neck Lymphoma in Guilan Province, Iran. Asian Pac J Cancer Prev. 2016;17:1-4.
11. Zapater E, Bagán JV, Carbonell F, Basterra J. Malignant lymphoma of the head and neck. Oral Dis. 2010;16(2):119-28.
12. Shima N, Kobashi Y, Tsutsui K, Ogawa K, Maetani SH, Nakashima Y, et al. Extranodal non-Hodgkin's lymphoma of the head and neck. A clinicopathologic study in the Kyoto-Nara area of Japan. Cancer. 1990; 66(6):1190-7.
13. Urquhart A, Berg R. Hodgkin's and non-Hodgkin's lymphoma of the head and neck. Laryngoscope. 2001;111(9):1565-9.
14. Shamloo N, Lotfi A, Motazadian HR, Mortazavi H, Baharvand M. Squamous Cell Carcinoma as the Most Common Lesion of the Tongue in Iranians: a 22-Year Retrospective Study. Asian Pac J Cancer Prev. 2016;17(3):1415-9.
15. Huh J. Epidemiologic overview of malignant lymphoma. Korean J Hematol. 2012;47(2):92-104.
16. Epstein JB, Epstein JD, Le ND, Gorsky M. Characteristics of oral and paraoral malignant lymphoma: a population-based review of 361 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 92(5):519-25.
17. Essadi I, Ismaili N, Tazi E, Elmajjaoui S, Saidi A, Ichou M, et al. Primary lymphoma of the head and neck: two case reports and review of the literature. Cases J. 2008;1(1):426.
18. Baris D, Zahm SH. Epidemiology of lymphomas. Curr Opin Oncol. 2000;12:383–94.
19. Glaser SL, Swartz WG. Time trends in Hodgkin's disease incidence. The role of diagnostic accuracy. Cancer. 1990; 66(10):2196–2204.
20. Glaser SL. Reproductive factors in Hodgkin's disease in women: a review. Am J Epidemiol. 1994; 139:237–46.
21. Kemp S, Gallagher G, Kabani S, Noonan V, O'Hara C. Oral non-Hodgkin's lymphoma: review of the literature and World Health Organization classification with reference to 40 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105:194-201.
22. Mani H, Jaffe ES. Hodgkin lymphoma: an update on its biology with new insights into classification. Clin Lymphoma Myeloma. 2009; 9: 206-16.
23. Jarrett RF. Viruses and Hodgkin's lymphoma. Ann Oncol. 2002;13(Suppl 1):23–9.
24. Zucca E, Roggero E, Bertoni F, Conconi A, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 2: Head and neck, central nervous system and other less common sites. Ann Oncol. 1999;10(9):1023-33.